◼ Archived
Business
🔮 fades ✓
What would it take to get peptides on the shelf?
NPR examines the regulatory and commercial hurdles involved in bringing peptide-based products to retail shelves.
Peptides
18 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
FDA Panel Backs 6 Peptides for Compounding
An FDA advisory panel has signaled support for easing restrictions on six specific peptides for compounding, sparking a debate over drug safety.
◼ Archived
Business
🔮 fades ✓
Millions could gain easier access to popular peptides after FDA panel vote
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Hot Peptide Summer Is Almost Here
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
An FDA panel's narrow vote backing four controversial peptides sparks rising concern over a potential prescribing boom.
◼ Archived
Business
🔮 fades
Trump Live Updates: FDA Peptide Meetings, Tariffs and Latest News
FDA advisers have narrowly voted to add six controversial peptides to a drug compounding list, signaling a shift in regulatory access.
◼ Archived
Business
🔮 fades
Trump Administration Live Updates: F.D.A. Advisers Hold More Meetings on Poorly Understood Peptides
FDA advisers vote to loosen rules on poorly understood peptides, sparking talk of a biotech gold rush.
◼ Archived
Business
🔮 fades
An FDA Panel Just Endorsed These Unproven Peptides
An FDA advisory panel has voted to add unproven peptides to a permitted list, sparking a conflict between advisers and agency scientists.
◼ Archived
Business
🔮 holds
A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda
An FDA advisory panel has voted to allow the compounding of unapproved peptides, signaling a potential conflict with agency scientists.
◼ Archived
Business
🔮 fades
FDA reviews peptide injections favored by RFK Jr. and wellness influencers
The FDA is reviewing restrictions on seven popular peptide injections, sparking a potential conflict between federal scientists and political agendas.
◼ Archived
Business
🔮 fades
Peptides get their regulatory closeup
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
The Great Peptide Cash Grab Has Begun
A pending FDA advisory panel vote on seven specific peptides could unlock a multibillion-dollar market for telehealth and longevity medicine.
◼ Archived
Health
🔮 fades
FDA raised conflict of interest concerns ahead of new peptide panel
Federal regulators face mounting scrutiny over potential conflicts of interest ahead of an upcoming vote on peptide substances.
◼ Archived
Health
🔮 fades
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?
FDA’s new peptide panel sparks regulatory debate as biotech giants Lilly and Novo eye the next health wave.
◼ Archived
Health
🔮 fades
Dear Doctor: Are drug companies suppressing peptide use because it’s a better, cheaper cure?
Growing public curiosity surrounds peptides as they emerge in discussions regarding skincare, male vitality, and general health benefits.
◼ Archived
Health
🔮 fades
Why experts say peptides just might be the secret to reviving thinning hair
Peptides surge into spotlight, from hair‑loss hopes to black‑market debates and a new U.S. fentanyl link.
◼ Archived
Health
🔮 fades
Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns
Medical experts and health organizations are raising alarms over the resurgence of an illicit tanning peptide often referred to as the Barbie drug.
◼ Archived
Health
🔮 fades
Peptide hype is at an all-time high
Peptide therapy has emerged as a major wellness trend, sparking concerns over the safety and regulatory status of products in a rapidly growing market.